Sign in

CIK 0001439725

  • Non-accelerated filer
  • Smaller reporting company

BIODESIX INC

Sign in to watch
Ticker
BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203986492
Phone
+1 303-417-0500
Business address
919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
  1. 4 Open-market sale Chief Commercial Officer sold 462 shares at an average $1.40 ($645)
  2. 4 Open-market sale President & CEO sold 3,740 shares at an average $1.40 ($5,220)
  3. 4 Open-market sale CFO, Sec'y & Treasurer sold 971 shares at an average $1.40 ($1,355)
  4. 4 Open-market buy Director bought 40,000 shares at $1.40 ($55,916)
  5. 4 Open-market buy Director bought 100,253 shares at $1.36 ($136,585)
  6. 4 Open-market buy Director bought 75,000 shares at $1.38 ($103,710)
  7. 4 Open-market buy Director bought 22,500 shares at $1.37 ($30,866)
  8. 4 Open-market buy Director bought 71,200 shares at an average $1.36 ($97,068)
  9. 4 Open-market sale Chief Accounting Officer sold 209 shares at an average $1.59 ($333)
  10. 4 Open-market sale Chief Development Officer sold 431 shares at an average $1.59 ($687)
  11. 4 Open-market sale Chief Commercial Officer sold 465 shares at an average $1.59 ($741)
  12. 4 Open-market sale President & CEO sold 3,744 shares at an average $1.59 ($5,966)
  13. 4 Open-market sale CFO, Sec'y & Treasurer sold 975 shares at an average $1.59 ($1,554)
  14. 4 Exercise or conversion Director acquired 26,368 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Exercise or conversion Chief Accounting Officer acquired 880 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 347,840 shares (option exercise)
  18. 4 Exercise or conversion Director acquired 86,960 shares (option exercise)
  19. 4 Exercise or conversion Chief Development Officer acquired 880 shares (option exercise)
  20. 4 Exercise or conversion Chief Commercial Officer acquired 13,080 shares (option exercise)

Page 5 of 17 · 336 filings